Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο: https://hdl.handle.net/123456789/833
Τύπος: Αναρτημένη ανακοίνωση (poster)
Τίτλος: Dabigatran inhibits the activation of endothelial progenitor cells induced by thrombin
Συγγραφέας: [EL] Παπαδάκη, Στυλιανή[EN] Papadaki, Stylianisemantics logo
[EL] Σιδηροπούλου, Σοφία[EN] Sidiropoulou, Sofiasemantics logo
[EL] Μοσχονάς, Ηρακλής[EN] Moschonas, Iraklissemantics logo
[EL] Τσελέπης, Αλέξανδρος[EN] Tselepis, Alexandrossemantics logo
Ημερομηνία: 31/08/2019
Περίληψη: Introduction: Thrombin is a coagulation serine protease, which also activates various cell types, including endothelial cells. Late-outgrowth endothelial cells (OECs) are a type of endothelial progenitor cells that contribute to endothelial regeneration and angiogenesis. Dabigatran is a direct oral anticoagulant that inhibits thrombin’s action and is widely used in everyday clinical practice. Purpose: We investigated the effect of dabigatran on thrombin-induced activation of OECs, using the membrane expression of adhesion molecule ICAM-1 as activation marker. Control experiments were conducted in mature human umbilical vein endothelial cells (HUVECs). Methods: CD34+ cells were isolated from cord blood mononuclear cells, using human CD34 Microbead Kit and appropriately cultured for OEC formation. HUVECs were purchased from Lonza. Confluent OECs and HUVECs were incubated with 10 or 20 μM dabigatran for 10 min, before activation with 8 U/mL thrombin, for 24 h. The effect of dabigatran on ICAM-1 expression (anti-CD54-PE) was evaluated in both cell types as % gated CD31+/CD54+ cells, using flow cytometry. Results: Thrombin induced ICAM-1 membrane expression by 33±15% on OECs and by 123±22% on HUVECs, compared with respective untreated cells (p<0.05 for both comparisons, from 6 different experiments). Dabigatran at 10 μM significantly inhibited ICAM-1 expression by 36±7% on OECs and 57±8% on HUVECs, as well as at 20 μM by 51±8% on OECs and 79±7% on HUVECs (p<0.05 for all comparisons, from 4 different experiments). Conclusions: We show for the first time that dabigatran at concentrations relevant to those existing in vivo after oral administration, inhibits the thrombin-induced membrane expression of the adhesion molecule ICAM-1 on OECs, a phenomenon that is also observed on mature endothelial cells. The significance of this effect regarding the pathophysiological role of OECs and mature endothelial cells at the clinical level remains to be established.
Γλώσσα: Αγγλικά
Τόπος δημοσίευσης: Paris, France
Σελίδες: 1
DOI: 10.1093/eurheartj/ehz745.0346
ISSN: 0195-668X
Θεματική κατηγορία: [EL] Άλλες Ιατρικές Επιστήμες[EN] Other Medical Sciencessemantics logo
Λέξεις-κλειδιά: Anticoagulants
Κάτοχος πνευματικών δικαιωμάτων: © The Author(s) 2019
Όροι και προϋποθέσεις δικαιωμάτων: Published on behalf of the European Society of Cardiology. For permissions, please email: journals.permissions@oup.com.
Διατίθεται ανοιχτά στην τοποθεσία: https://www.researchgate.net/publication/336693866_Dabigatran_inhibits_the_activation_of_endothelial_progenitor_cells_induced_by_thrombin
https://esc365.escardio.org/Congress/ESC-CONGRESS-2019/Poster-Session-4-Anticoagulant-therapy/197331-dabigatran-inhibits-the-activation-of-endothelial-progenitor-cells-induced-by-thrombin#abstract
Ηλεκτρονική διεύθυνση του τεκμηρίου στον εκδότη: https://esc365.escardio.org/Congress/ESC-CONGRESS-2019/Poster-Session-4-Anticoagulant-therapy/197331-dabigatran-inhibits-the-activation-of-endothelial-progenitor-cells-induced-by-thrombin#abstract
https://academic.oup.com/eurheartj/article-abstract/40/Supplement_1/ehz745.0346/5597734
Ηλεκτρονική διεύθυνση περιοδικού: https://academic.oup.com/eurheartj
Τίτλος πηγής δημοσίευσης: European Heart Journal
Τεύχος: Supplement 1
Τόμος: 40
Σελίδες τεκμηρίου (στην πηγή): Article no P3475
Όνομα εκδήλωσης: ESC Congress 2019 together with the World Congress of Cardiology
Τοποθεσία εκδήλωσης: Paris, France
Ημ/νία έναρξης εκδήλωσης: 31/08/2019
Ημ/νία λήξης εκδήλωσης: 04/09/2019
Σημειώσεις: We thank the Atherothrombosis Research Centre of the University of Ioannina for providing access to laboratory facilities. This research has been co-financed by the Operational Program “Human Resources Development, Education and Lifelong Learning” and is co-financed by the European Union (European Social Fund) and Greek national funds.
Εμφανίζεται στις συλλογές:Ερευνητικές ομάδες

Αρχεία σε αυτό το τεκμήριο:
Αρχείο Περιγραφή ΣελίδεςΜέγεθοςΜορφότυποςΈκδοσηΆδεια
Papadaki-Poster.pdf796.02 kBAdobe PDF-inceduΔείτε/ανοίξτε